نتایج جستجو برای: medulloblastoma

تعداد نتایج: 5231  

2016
Irina Alimova June Ng Peter Harris Diane Birks Andrew Donson Michael D. Taylor Nicholas K. Foreman Sujatha Venkataraman Rajeev Vibhakar

Medulloblastoma is the most common type of malignant brain tumor that affects children. Although recent advances in chemotherapy and radiation have improved outcomes, high-risk patients perform poorly with significant morbidity. Gene expression profiling has revealed that monopolar spindle 1 (MPS1) (TTK1) is highly expressed in medulloblastoma patient samples compared to that noted in normal ce...

2016
Eric W. Prince Ilango Balakrishnan Monil Shah Jean M. Mulcahy Levy Andrea M. Griesinger Irina Alimova Peter S. Harris Diane K. Birks Andrew M. Donson Nathan Davidson Marc Remke Michael D. Taylor Michael H. Handler Nicholas K. Foreman Sujatha Venkataraman Rajeev Vibhakar

Checkpoint kinase 1 (CHK1) is an integral component of the cell cycle as well as the DNA Damage Response (DDR) pathway. Previous work has demonstrated the effectiveness of inhibiting CHK1 with small-molecule inhibitors, but the role of CHK1 mediated DDR in medulloblastoma is unknown. CHK1, both at the mRNA and protein level, is highly expressed in medulloblastoma and elevated CHK1 expression in...

2016
Tonny Lagerweij Lotte Hiddingh Dennis Biesmans Matheus H.W. Crommentuijn Jacqueline Cloos Xiao-Nan Li Mari Kogiso Bakhos A. Tannous W. Peter Vandertop David P. Noske Gertjan J.L. Kaspers Tom Würdinger Esther Hulleman

Treatment of medulloblastoma in children fails in approximately 30% of patients, and is often accompanied by severe late sequelae. Therefore, more effective drugs are needed that spare normal tissue and diminish long-term side effects. Since radiotherapy plays a pivotal role in the treatment of medulloblastoma, we set out to identify novel drugs that could potentiate the effect of ionizing radi...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Amar Gajjar Stefan M Pfister Michael D Taylor Richard J Gilbertson

High-throughput genomic technologies have shed light on the biologic heterogeneity of several pediatric brain tumors. The biology of the four common pediatric brain tumors-namely medulloblastoma; ependymoma; high-grade glioma (HGG), including diffuse intrinsic pontine glioma; and low-grade glioma-is highlighted in this CCR Focus article. The discovery that medulloblastoma consists of four diffe...

Journal: :Neurology India 2017
Tejpal Gupta Chitra Sarkar Vedantam Rajshekhar Sandip Chatterjee Neelam Shirsat Dattatreya Muzumdar Sona Pungavkar Girish Chinnaswamy Rakesh Jalali

INTRODUCTION The high success rate in the management medulloblastoma achieved in the western world is not exactly mirrored in developing countries including India. Socio-demographic differences, health-care disparity, and lack in uniformity of care with resultant widespread variations in the clinical practice are some of the reasons that may partly explain this difference in outcomes. Patients ...

Journal: :Folia neuropathologica 2004
Ewa Cieślak Lucyna Kepka Jacek Fijuth Andrzej Marchel Halina Kroh

A case of 47-year-old woman with a local relapse of medulloblastoma 23 years after initial presentation is reported. At the age of 24, the patient underwent resection of medulloblastoma of the right cerebellar lobe, followed by the craniospinal orthovoltage irradiation (3600 R to the brain, and 3000 R to the spinal cord). At the 21st year of follow-up, a second cancer originating in the thyroid...

2015
Kedar Yogi Epari Sridhar Naina Goel Rakesh Jalali Atul Goel Aliasgar Moiyadi Rahul Thorat Pooja Panwalkar Atul Khire Archya Dasgupta Prakash Shetty Neelam Vishwanath Shirsat

Medulloblastoma, a common pediatric malignant brain tumor consists of four molecular subgroups viz. WNT, SHH, Group 3 and Group 4. MiR-148a is over-expressed in the WNT subgroup tumors, which have the lowest incidence of metastasis and excellent survival among all medulloblastomas. MiR-148a was expressed either in a transient manner using a synthetic mimic or in a stable doxycycline inducible m...

2014
Hideto Koso Asano Tsuhako Eli Lyons Jerrold M. Ward Alistair G. Rust David J. Adams Nancy A. Jenkins Neal G. Copeland Sumiko Watanabe

Medulloblastoma is the most common pediatric brain tumor, and in 25% of cases, it is driven by aberrant activation of the Sonic Hedgehog (SHH) pathway in granule neuron precursor (GNP) cells. In this study, we identified novel medulloblastoma driver genes through a transposonmutagenesis screen in the developing brain of wild-type and Trp53 mutant mice. Twenty-six candidates were identified alon...

Background: Medulloblastoma is the most common malignant brain tumor in children. The important factors in predicting survival are the extent of disease, proliferation index of the tumor cells, histopathologic class and the age at diagnosis. The percentage of Ki-67 positive cells reflects the proliferation  of the cells and is one of the critical factors which determine the growth of the tumor....

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2014
Pratiti Bandopadhayay Guillaume Bergthold Brian Nguyen Simone Schubert Sharareh Gholamin Yujie Tang Sara Bolin Steven E Schumacher Rhamy Zeid Sabran Masoud Furong Yu Nujsaubnusi Vue William J Gibson Brenton R Paolella Siddhartha S Mitra Samuel H Cheshier Jun Qi Kun-Wei Liu Robert Wechsler-Reya William A Weiss Fredrik J Swartling Mark W Kieran James E Bradner Rameen Beroukhim Yoon-Jae Cho

PURPOSE MYC-amplified medulloblastomas are highly lethal tumors. Bromodomain and extraterminal (BET) bromodomain inhibition has recently been shown to suppress MYC-associated transcriptional activity in other cancers. The compound JQ1 inhibits BET bromodomain-containing proteins, including BRD4. Here, we investigate BET bromodomain targeting for the treatment of MYC-amplified medulloblastoma. ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید